Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA

Brain Pathology

Volumn 9, Issue 3, 1999, Pages 481-493

  Tsunoda, Ikuo ^a   Tolley, Neal D ^a   Theil, Diethilde J ^a   Whitton, J Lindsay ^b   Kobayashi, Hiroko ^c   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CYTOKINE; ENCEPHALITOGENIC PROTEIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; IMMUNOSTIMULATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NATURAL KILLER CELL; NONHUMAN; PLASMID; VACCINATION;

EID: 0032976985     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1999.tb00537.x     Document Type: Article

References (64)

1. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383: 787-793
2. Barnett LA, Whitton JL, Wada Y, Fujinami RS (1993) Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein [published erratum appears in J Neuroimmunol 1993;48:120]. J Neuroimmunol 44: 15-25
3. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186: 1623-1631
4. Croxford JL, Triantaphyllopoulos K, Podhajcer OL, Feldmann M, Baker D, Chernajovsky Y (1998) Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system. J Immunol 160: 5181-5187
5. D'Souza S, Alinauskas K, McCrea E, Goodyer C, Antel JP (1995) Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 15: 7293-7300
6. Dalgleish AG (1997) Viruses and multiple sclerosis. Acta Neurol Scand Suppl 169: 8-15
7. Donnelly SM, Sheahan BJ, Atkins GJ (1997) Long-term effects of Semliki Forest virus infection in the mouse central nervous system. Neuropathol Appl Neurobiol 23: 235-241
8. Greer JM, Kuchroo VK, Sobel RA, Lees MB (1992) Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J Immunol 149: 783-788
9. Hassett DE, Whitton JL (1996) DNA immunization. Trends Microbiol 4: 307-312
10. Hill KE, Pigmans M, Fujinami RS, Rose JW (1998) Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10. J Neuroimmunol 85: 44-51
11. Iwasaki Y, Sako K, Tsunoda I, Ohara Y (1993) Phenotypes of mononuclear cell infiltrates in human central nervous system. Acta Neuropathol (Berl) 85: 653-657
12. Kaminsky SG, Nakamura I, Cudkowicz G (1983) Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: Low responsiveness to interferon inducers. J Immunol 130: 1980-1984
13. Karlin S, Doerfler W, Cardon LR (1994) Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J Virol 68: 2889-2897
14. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, Krieg AM (1998) Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 160: 2555-2559
15. Klinman DM, Yi A-K, Beaucage SL, Conover J, Krieg AM (1996) CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc Natl Acad Sci USA 93: 2879-2883
16. Krieg AM (1995) CpG DNA: A pathogenic factor in systemic lupus erythematosus? J Clin Immunol 15: 284-292
17. Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549
18. Kurtz CIB, Sun X, Fujinami RS (1995) Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus. Microb Pathog 18: 11-27
19. Kurtzke JF (1997) The epidemiology of multiple sclerosis. In: Multiple Sclerosis: Clinical and Pathogenetic Basis. Raine CS, McFarland HF, Tourtellotte WW (eds.), Chapter 7, pp. 91-139, Chapman & Hall, London.
20. Lipton HL (1996) Theiler's viruses. In: Enclycopedia of Virology plus CD-ROM product. Webster RG, Granoff A (eds.) Academic Press, London.
21. Lobell A, Weissert R, Storch MK, Svanholm C, de Graaf KL, Lassmann H, Andersson R, Olsson T, Wigzell H (1998) Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J Exp Med 187: 1543-1548
22. Miller SD, Karpus WJ (1994) The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today 15: 356-361
23. Navikas V, Link H (1996) Cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45: 322-333
24. O'Garra A (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8: 275-283
25. Panitch HS (1994) Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 36 Suppl: S25-S28
26. Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987) Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. Neurology 37: 1097-1102
27. Pender MP, Nguyen KB, McCombe PA, Kerr JF (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104: 81-87
28. Pisetsky DS (1997) Immunostimulatory DNA: A clear and present danger? Nat Med 3: 829-831
29. Pullen LC, Miller SD, Dal Canto MC, Van der Meide PH, Kim BS (1994) Alteration in the level of Interferon-γ results in acceleration of Theiler's virus-induced demyelinating disease. J Neuroimmunol 55: 143-152
30. Rapp NS, Gilroy J, Lerner AM (1995) Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil 74: 415-418
31. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M (1990) Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33: 1665-1673
32. Rivera-Quiñones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M (1998) Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med 4: 187-193
33. Rodriguez M, Lafuse WP, Leibowitz J, David CS (1986) Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology 36: 964-970
34. Rodriguez M, Pavelko K, Coffman RL (1995) Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J Virol 69: 7286-7290
35. Rodriguez M, Pavelko KD, McKinney CW, Leibowitz JL (1994) Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J Immunol 153: 3811-3821
36. Rodriguez M, Quddus J (1986) Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination. J Neuroimmunol 13: 159-174
37. Roman M, Martin-Orozco E, Goodman JS, Nguyen M-D, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA, Raz E (1997) Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3: 849-854
38. Rose JW, Hill KE, Wada Y, Kurtz CIB, Tsunoda I, Fujinami RS, Cross AH (1998) Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection. J Neuroimmunol 81: 82-89
39. Sato S, Reiner SL, Jensen MA, Roos RP (1997) Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. J Neuroimmunol 76: 213-223
40. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen M-D, Silverman GJ, Lotz M, Carson DA, Raz E (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352-354
41. Schwartz DA, Quinn TJ, Thorne PS, Sayeed S, Yi A-K, Krieg AM (1997) CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest 100: 68-73
42. Segal BM, Klinman DM, Shevach EM (1997) Microbial products induce autoimmune disease by an IL-12-dependent pathway. J Immunol 158: 5087-5090
43. Sparwasser T, Miethke T, Lipford G, Borschert K, Häcker H, Heeg K, Wagner H (1997) Bacterial DNA causes sep-tic shock. Nature 386: 336-337
44. Sriram S, Mitchell W, Stratton C (1998) Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology 50: 571-572
45. Stacey KJ, Sweet MJ, Hume DA (1996) Macrophages ingest and are activated by bacterial DNA. J Immunol 157: 2116-2122
46. Tanuma N, Matsumoto Y (1997) Recent advances in the immunopathology of experimental autoimmune encephalomyelitis: With special reference to cytokine production in the central nervous system. Neuropathology 17: 152-159
47. Taubes G (1997) Salvation in a snippet of DNA? Science 278: 1711-1714
48. Theil D, Tsunoda I, Libbey JE, Fujinami RS (1999) Chemokine and cytokine mRNA expression in GDVII, DA and H101 strains of TMEV infection. (Abstract) A Keystone Symposium, Infections of the Nervous System: Host-Pathogen Interactions, Taos, New Mexico, p. 26
49. Tighe H, Corr M, Roman M, Raz E (1998) Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 19: 89-97
50. Tsunoda I, Fujinami RS (1996) Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 55: 673-686
51. Tsunoda I, Iwasaki Y, Terunuma H, Sako K, Ohara Y (1996) A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus. Acta Neuropathol (Berl) 91: 595-602
52. Tsunoda I, Kuang L-Q, Tolley ND, Whitton JL, Fujinami RS (1998) Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol 57: 758-767
53. Tsunoda I, Kurtz CIB, Fujinami RS (1997) Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology 228: 388-393
54. Tsunoda I, McCright IJ, Kuang L-Q, Zurbriggen A, Fujinami RS (1997) Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J Neuropathol Exp Neurol 56: 1302-1313
55. Waisman A, Ruiz PJ, Hirschberg DL, Gelman A, Oksenberg JR, Brocke S, Mor F, Cohen IR, Steinman L (1996) Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity [see comments]. Nat Med 2: 899-905
56. Yamada M, Zurbriggen A, Fujinami RS (1991) Pathogenesis of Theiler's murine encephalomyelitis virus. Adv Virus Res 39: 291-320
57. Yamamoto S, Kuramoto E, Shimada S, Tokunaga T (1988) in vitro augmentation of natural killer cell activity and production of interferon-α/β and -γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 79: 866-873
58. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T (1992) Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol 148: 4072-4076
59. Yamamoto S, Yamamoto T, Shimada S, Kuramoto E, Yano O, Kataoka T, Tokunaga T (1992) DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 36: 983-997
60. L. J Immunol 157: 4918-4925
61. Yokoyama M, Zhang J, Whitton JL (1995) DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol 69: 2684-2688
62. Young HA, Ghosh P, Ye J, Lederer J, Lichtman A, Gerard JR, Penix L, Wilson CB, Melvin AJ, McGurn ME, Lewis DB, Taub DD (1994) Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-γ gene. J Immunol 153: 3603-3610
63. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Röcken M, Wagner H, Heeg K (1998) CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol 160: 3627-3630
64. Zurbriggen A, Fujinami RS (1988) Theiler's virus infection in nude mice: Viral RNA in vascular endothelial cells. J Virol 62: 3589-3596